JW Therapeutics (Shanghai) Co.
Latest round
- Series B
Last raised
- Jun 2020
Total raised
- $190M
Investors
- 13
About JW Therapeutics (Shanghai) Co.
, Ltd. specializes in cell immunotherapy, with headquarters in Shanghai, China. The company was established by James Li, who has previous entrepreneurial experience.JW Therapeutics primarily focuses on developing, producing, and commercializing cell immunotherapy products for hematological malignancies, solid tumors, and autoimmune diseases. Their flagship CAR-T therapy, Ruiqiolun (commercially branded as Benoda®), received market approval from the National Medical Products Administration (NMPA) in September 2021.JW Therapeutics generates revenue primarily through the sale of its proprietary CAR-T therapy products, which are distributed to certified healthcare institutions following comprehensive training and certification. The pricing of their products aligns with industry standards for advanced biopharmaceutical therapies.Looking ahead, JW Therapeutics plans to expand its portfolio with new products aimed at addressing additional oncology indications.330 billion will support these initiatives. Furthermore, they aim to penetrate international markets in upcoming years, leveraging their proven technology and therapeutic offerings to enhance patient outcomes globally.
Who invested in JW Therapeutics (Shanghai) Co.
13 investors across 2 rounds
See all investors in JW Therapeutics (Shanghai) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about JW Therapeutics (Shanghai) Co.
Who invested in JW Therapeutics (Shanghai) Co.?
JW Therapeutics (Shanghai) Co. has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has JW Therapeutics (Shanghai) Co. raised?
JW Therapeutics (Shanghai) Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did JW Therapeutics (Shanghai) Co. last raise money?
JW Therapeutics (Shanghai) Co.'s most recent round on record is a Series B, in Jun 2020.
What does JW Therapeutics (Shanghai) Co. do?
JW Therapeutics (Shanghai) Co. is a biotechnology company.
Where is JW Therapeutics (Shanghai) Co. headquartered?
JW Therapeutics (Shanghai) Co. is headquartered in Shanghai, China.
Which VCs invest in companies like JW Therapeutics (Shanghai) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at JW Therapeutics (Shanghai) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like JW Therapeutics (Shanghai) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.